StockNews.com Begins Coverage on Milestone Scientific (NYSE:MLSS)

Investment analysts at StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSSGet Free Report) in a research report issued on Monday. The firm set a “hold” rating on the stock.

Separately, Benchmark restated a “speculative buy” rating and issued a $1.25 price objective on shares of Milestone Scientific in a research note on Wednesday, November 20th.

View Our Latest Analysis on MLSS

Milestone Scientific Trading Up 0.9 %

MLSS stock opened at $1.09 on Monday. The stock has a market cap of $84.90 million, a P/E ratio of -15.57 and a beta of 1.10. Milestone Scientific has a twelve month low of $0.54 and a twelve month high of $1.27. The company’s 50 day moving average is $0.87 and its two-hundred day moving average is $0.90.

Insider Buying and Selling at Milestone Scientific

In other news, Director Leonard Osser sold 107,984 shares of the stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $0.93, for a total value of $100,425.12. Following the completion of the transaction, the director now owns 4,606,882 shares in the company, valued at $4,284,400.26. This trade represents a 2.29 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 24.75% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in MLSS. Y Intercept Hong Kong Ltd purchased a new position in shares of Milestone Scientific in the third quarter valued at $48,000. Geode Capital Management LLC increased its holdings in Milestone Scientific by 6.4% during the 3rd quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock valued at $480,000 after acquiring an additional 31,572 shares in the last quarter. Finally, World Investment Advisors LLC acquired a new position in Milestone Scientific during the third quarter worth about $91,000. 5.79% of the stock is owned by hedge funds and other institutional investors.

Milestone Scientific Company Profile

(Get Free Report)

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.

Read More

Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.